2025 first_quarter Filing
Q1Income
$60K
Filed
April 21, 2025
Lobbying Activities
PharmacyView all
Issues related to prescription drug value, including H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; and implementation of the Inflation Reduction Act (PL 117-169). Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including H.R. 2882, FY2024 Further Consolidated Appropriations Act. Issues related to the 340B program.
Contacted:Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Trade (domestic/foreign)View all
Issues related to tariff and trade policy.
Contacted:HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
Lobbyists (2)
HAZEN CLAY MARSHALL
MONICA POPP